107
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Role of Adiponectin Gene and Receptor Polymorphisms and Their mRNA Levels with Serum Adiponectin Level in Myocardial Infarction

ORCID Icon, ORCID Icon, &
Pages 241-252 | Published online: 18 Dec 2020

References

  • Xu S, Jiang J, Zhang Y, et al. Discovery of potential plasma protein biomarkers for acute myocardial infarction via proteomics. J Thorac Dis. 2019;11(9):3962–3972. doi:10.21037/jtd.2019.08.100
  • Luan L, Hu H, Li SC. A review of studies of quality of life for Chinese-speaking patients with ischemic heart disease. Value Health Reg Issues. 2018;15:82–90. doi:10.1016/j.vhri.2017.08.013
  • Barsova RM, Lvovs D, Titov BV, et al. Variants of the coagulation and inflammation genes are replicably associated with myocardial infarction and epistatically interact in Russians. Zhang H, ed. PLoS One. 2015;10(12):e0144190. doi:10.1371/journal.pone.0144190
  • Hirokawa M, Morita H, Tajima T, et al. A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese. Eur J Hum Genet. 2015;23(3):374–380. doi:10.1038/ejhg.2014.110
  • Shah N, Kelly AM, Cox N, Wong C, Soon K. Myocardial infarction in the “young”: risk factors, presentation, management and prognosis. Heart Lung Circ. 2016;25(10):955–960. doi:10.1016/j.hlc.2016.04.015
  • Rodríguez-Pérez JM, Posadas-Sánchez R, Blachman-Braun R, et al. HHIPL-1 (rs2895811) gene polymorphism is associated with cardiovascular risk factors and cardiometabolic parameters in Mexican patients with myocardial infarction. Gene. 2018;663:34–40. doi:10.1016/j.gene.2018.04.030
  • Kyriakou T, Collins LJ, Spencer-Jones NJ, et al. Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet. 2008;53(8):718–727. doi:10.1007/s10038-008-0303-1
  • Banerjee A, Khemka VK, Roy D, Poddar J, Roy TKS, Karnam SA. Role of serum adiponectin and vitamin D in prediabetes and diabetes mellitus. Can J Diabetes. 2017;41(3):259–265. doi:10.1016/j.jcjd.2016.10.006
  • Méndez-Hernández A, Gallegos-Arreola MP, Moreno-Macías H, Espinosa Fematt J, Pérez-Morales R. LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 polymorphisms are associated with obesity and chemotherapy response in Mexican women with breast cancer. Clin Breast Cancer. 2017;17(6):453–462. doi:10.1016/j.clbc.2017.03.010
  • Wang Y, Wang X, Lau WB, et al. Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation. Circ Res. 2014;114(5):792–805. doi:10.1161/CIRCRESAHA.114.302439
  • Li TD, Zeng ZH. Adiponectin as a potential therapeutic target for the treatment of restenosis. Biomed Pharmacother. 2018;101:798–804. doi:10.1016/j.biopha.2018.03.003
  • Martinez-Huenchullan SF, Tam CS, Ban LA, Ehrenfeld-Slater P, Mclennan SV, Twigg SM. Skeletal muscle adiponectin induction in obesity and exercise. Metabolism. 2020;102:154008. doi:10.1016/j.metabol.2019.154008
  • Blüher M, Williams CJ, Klöting N, et al. Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care. 2007;30(12):3110–3115. doi:10.2337/dc07-1257
  • Kollias A, Tsiotra PC, Ikonomidis I, et al. Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovasc Diabetol. 2011;10(1):14. doi:10.1186/1475-2840-10-14
  • De Caterina R, Talmud PJ, Merlini PA, et al. Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction. Atherosclerosis. 2011;214(2):397–403. doi:10.1016/j.atherosclerosis.2010.11.011
  • Zhang M, Peng Y, Lyu S. Association between genetic variants in the adiponectin gene and premature myocardial infarction. Chin J Cardiol. 2016;44(7):577–582. doi:10.3760/cma.j.issn.0253-3758.2016.07.005
  • Hui X, Lam KS, Vanhoutte PM, Xu A. Adiponectin and cardiovascular health: an update. Br J Pharmacol. 2012;165(3):574–590. doi:10.1111/j.1476-5381.2011.01395.x
  • Turer AT, Scherer PE. Adiponectin: just along for the ride? Circ Res. 2016;119(3):407–408. doi:10.1161/CIRCRESAHA.116.309226
  • Pang TTL, Narendran P. The distribution of adiponectin receptors on human peripheral blood mononuclear cells. In: Annals of the New York Academy of Sciences. Vol. 1150. Blackwell Publishing Inc.; 2008:143–145. doi:10.1196/annals.1447.021
  • Halvatsiotis I, Tsiotra PC, Ikonomidis I, et al. Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes. Cardiovasc Diabetol. 2010;9:10. doi:10.1186/1475-2840-9-10
  • Li S, Shin HJ, Ding EL, Van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–188. doi:10.1001/jama.2009.976
  • Liberale L, Carbone F, Bertolotto M, et al. Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis. Vascul Pharmacol. 2018;102:37–43. doi:10.1016/j.vph.2017.12.066
  • Gan L, Yang L, Yan G. Predict value of adiponectin for coronary atherosclerosis plaques according to computed tomography angiography in an asymptomatic population. Clin Imaging. 2018;51:174–179. doi:10.1016/j.clinimag.2018.05.019
  • Wang Y, Zheng A, Yan Y, et al. Association between HMW adiponectin, HMW-total adiponectin ratio and early-onset coronary artery disease in Chinese population. Atherosclerosis. 2014;235(2):392–397. doi:10.1016/j.atherosclerosis.2014.05.910
  • Khan UI, Wang D, Sowers MR, et al. Race-ethnic differences in adipokine levels: the Study of Women’s Health Across the Nation (SWAN). Metabolism. 2012;61(9):1261–1269. doi:10.1016/j.metabol.2012.02.005
  • Mente A, Razak F, Blankenberg S, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care. 2010;33(7):1629–1634. doi:10.2337/dc09-1392
  • Zhou D, Jin Y, Yao F, Duan Z, Wang Q, Liu J. Association between the adiponectin +45T>G genotype and risk of cardiovascular disease: a meta-analysis. Heart Lung Circ. 2014;23(2):159–165. doi:10.1016/j.hlc.2013.07.010
  • Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4(2):45–61. doi:10.1097/00125817-200203000-00002
  • Kanu JS, Qiu S, Cheng Y, et al. Associations between three common single nucleotide polymorphisms (rs266729, rs2241766, and rs1501299) of ADIPOQ and cardiovascular disease: a meta-analysis. Lipids Health Dis. 2018;17(1). doi:10.1186/s12944-018-0767-8
  • Hussain MK, Almayali AH, Baqir Aljabery HA, Kamil ZD. Adeponectin gene polymorphism, rs2241766, is associated with coronary artery disease in Iraqi population. Gene Rep. 2019;14:50–53. doi:10.1016/j.genrep.2018.11.007
  • Zhang Z, Li Y, Yang X, Wang L, Xu L, Zhang Q. Susceptibility of multiple polymorphisms in ADIPOQ, ADIPOR1 and ADIPOR2 genes to myocardial infarction in Han Chinese. Gene. 2018;658:10–17. doi:10.1016/j.gene.2018.03.022
  • Heid IM, Wagner SA, Gohlke H, et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1727 healthy Caucasians. Diabetes. 2006;55(2):375–384. doi:10.2337/diabetes.55.02.06.db05-0747
  • Chang Y-C, Jiang J-Y, Jiang Y-D, et al. Interaction of ADIPOQ genetic polymorphism with blood pressure and plasma cholesterol level on the risk of coronary artery disease. Circ J. 2009;73(10):1934–1938. doi:10.1253/circj.CJ-09-0228
  • Filippi E, Sentinelli F, Romeo S, et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years). J Mol Med. 2005;83(9):711–719. doi:10.1007/s00109-005-0667-z
  • Yang Y, Zhang F, Ding R, Wang Y, Lei H, Hu D. Association of ADIPOQ gene polymorphisms and coronary artery disease risk: a meta-analysis based on 12 465 subjects. Thromb Res. 2012;130(1):58–64. doi:10.1016/j.thromres.2012.01.018
  • Ghazouani L, Elmufti A, Baaziz I, Chaabane I, Ben Mansour H. Contribution of adiponectin polymorphisms to the risk of coronary artery disease in a North-African Tunisian population. J Clin Lab Anal. 2018;32(7):e22446. doi:10.1002/jcla.22446
  • Yan CJ, Li SM, Xiao Q, et al. Influence of serum adiponectin level and SNP +45 polymorphism of adiponectin gene on myocardial fibrosis. J Zhejiang Univ Sci B. 2013;14(8):721–728. doi:10.1631/jzus.BQICC707
  • de Luis DA, Izaola O, Primo D, et al. Role of rs1501299 variant in the adiponectin gene on total adiponectin levels, insulin resistance and weight loss after a Mediterranean hypocaloric diet. Diabetes Res Clin Pract. 2019;148:262–267. doi:10.1016/j.diabres.2017.11.007
  • Lisowska A, Tycinska A, Knapp M, et al. Adiponectin an independent marker of coronary artery disease occurrence rather than a degree of its advancement in comparison to the IMT values in peripheral arteries. Clin Chim Acta. 2012;413(7–8):749–752. doi:10.1016/j.cca.2012.01.006
  • Piñeiro R, Iglesias MJ, Gallego R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005;579(23):5163–5169. doi:10.1016/j.febslet.2005.07.098
  • Kanu JS, Gu Y, Zhi S, et al. Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study. Lipids Health Dis. 2016;15(1):6. doi:10.1186/s12944-015-0173-4
  • Siitonen N, Pulkkinen L, Lindström J, et al. Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Cardiovasc Diabetol. 2011;10:83. doi:10.1186/1475-2840-10-83
  • Monzo L, Kotrc M, Benes J, et al. Clinical and humoral determinants of congestion in heart failure: potential role of adiponectin. Kidney Blood Press Res. 2019;44(5):1271–1284. doi:10.1159/000502975
  • Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112(12):1756–1762. doi:10.1161/CIRCULATIONAHA.104.530972